MSN reports that researchers with the University of California at San Diego are preparing to explore the administration of cannabidiol (CBD) as a possible treatment strategy for the more severe symptoms of Autism Spectrum Disorder (ASD).
After having received a $4.7 million dollar gift, researchers at University of California at San Diego’s Center for Medicinal Cannabis Research (CMCR) are now preparing to conduct clinical research involving 30 children between the ages of 8 and 12 years old, all whom struggle with symptoms categorized as being within the Autism Spectrum Disorder but who are otherwise healthy. According to Dr. Igor Grant, Director of the Center for Medicinal Cannabis Research:
” There are unconfirmed reports that cannabidiol could be helpful, but there are no careful studies to document either its benefits or its safety.”
This study could effectively invalidate or validate CBD’s effectiveness in treating the symptoms of ASD. Additionally, CBD continues to make strides in research recommending it as a treatment for other neuropsychological conditions including Dravet Syndrome and other forms of severe conditions under the epilepsy umbrella, in addition to dramatically reducing the likelihood of relapse in those who suffer from addiction to alcohol, cocaine, or other highly addictive substances.